Current knowledge of cervical cancer: classification, diagnosis, prevention, and treatment. Part II

Urszula Stępień; Dariusz Duma; Janusz Solski

doi:10.12923/

Authors

Urszula Stępień Cytology Department, Rotunda Hospital, Dublin, Ireland Author
Dariusz Duma Department of Laboratory Diagnostics, Medical University of Lublin, Poland Author
Janusz Solski Department of Laboratory Diagnostics, Medical University of Lublin, Poland Author

DOI:

https://doi.org/10.12923/

Abstract

Cervical cancer kills more than 288,000 women each year. The best protection of woman against developing cervical cancer is having regular cervical smear test. The majority of cervical cancers occur in women who have never been screened. The mortality from cervical cancer has decreased since the introduction of the conventional Papanicolaou smear. LBC is a newer method that is gradually replacing the conventional smear. The liquid-based preparation (LBP) has become the primary method for cervicovaginal screening because of the improved specimen quality and detection of squamous intraepithelial lesions The aim of cervical screening is to identify the precursor lesion of cancer. BSCC or CIN terminology is commonly used in UK and Ireland.

References

1. Aklimunnessa K. et al.: Effectiveness of cervical cancer screening over cervical cancer mortality among japanese women. Jap. J. Clin. Oncol., 36(8), 511, 2006.

2. Aristizabal N., Cuello C., Correa P. et al.: The impact of vaginal cytology on cervical Cancer risks in Cali, Colombia. Int. J. Cancer, 34 (1), 5, 1984.

3. Bosch F. X. et al.: Prevalence of human Papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst., 87(11),796, 1995.

4. Clarke E. A., Anderson T. W.: Does screening by "Pap" smears help prevent cervical Cancer? A case-control study. Lancet, 2 (8132), 1, 1979.

5. Denton K. J., Herbert A., Turnbull L. S. et al.: The revised BSCC terminology for abnormal cervical cytology. Cytopathology, 19(3), 137, 2008.

6. Doyle B., O’Farrell C., Mahoney E. et al.: Liquid-based cytology improves productivity in cervical cytology screening. Cytopathology, 17, 60, 2006.

7. Gaur D. S., Kishore S., Kusum A. et al.: Tubal metaplasia of the endocervix. J. Cytol., 25, 33, 2008.

8. Herrero R., Brinton L. A., Reeves W. C. et al.: Screening for cervical cancer in Latin America: a case-control study. Int. J. Epidemiol., 21(6), 1050, 1992.

9. Hildesheim A., Hadjimichael O., Schwartz P. E. et al.: Risk factors for rapid-onset cervical cancer. Am. J. Obstet. Gynecol., 180(3), 571, 1999.

10. International Agency for Research on Cancer Working Group on Evaluation of Cervical Cancer Screening Programmes. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. BMJ, 293, 659, 1986.

11. Janerich D. T., Hadjimichael O., Schwartz P. E. et al.: The screening histories of women with invasive cervical cancer. Am. J. Public Health, 85(6), 791, 1995.

12. Koss L.: The Papanicolaou test for cervical cancer detection: A triumph and a tragedy. JAMA, 154, 264, 1989.

13. La Veccchia C., Franceschi S., Decarli A. et al.: "Pap" smear and the risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet, 2 (8406), 779, 1984.

14. Melnikow J., Nuovo J.: Reducing mortality due to cervical cancer. PAPNET fails the test. Arch. Fam. Med. 8, 56, 1999.

15. National Institute for Clinical Excellence, London (2003): Guidance on the use of liquid base cytology for cervical screening.

16. Punia J., Klimowicz T., Davis S., Stark A.: Rejected and unsatisfactory specimens: A comparative study of liquid-based (SurePath) preparations and conventional Pap smears for cervicovaginal screening. Lab. Med., 38(12), 729, 2007.

17. Robinson-Bennett B.: Can 2009 herald a new era in preventing cervical cancers? J. Carcinog., 8, 1, 2009.

18. Smith R.A., Cokkinides V., von Eschenbach A.C. et al.: American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J. Clin., 52(1), 8, 2002.

19. Stein S. R.: ThinPrep versus the conventional Papanicolaou test: a review of specimen adequacy, sensitivity, and cost-effectiveness. Prim. Care Update Ob. Gyns., 10 (6), 310, 2003.

20. Wilkinson E. J.: Pap smears and screening for cervical neoplasia. Clin. Obstet. Gynecol., 33, 817, 1990.